Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids
Clinical trial NCT00459277 · COMPLETED
Trial details
- NCT number
- NCT00459277
- Sponsor
- Archimedes Development Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-07-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.